A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC36 Tablets for Oral Use in Adult Participants With Obesity or Overweight

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a randomized, placebo-controlled, double-blind, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of ASC36 Tablets for Oral Use in Adult Participants with Obesity or Overweight
Epistemonikos ID: f96d8c43706d6b86cf67d9170198fb497f21f70c
First added on: Oct 24, 2026